se of Thromboelastography (blood test) for liver disease
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Non Variceal Bleed
- Registration Number
- CTRI/2019/01/016978
- Lead Sponsor
- Institute of liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
Inclusion Criteria
1) Age more than 18
2) All patient with Non Variceal bleed
3) Patient with history of upper gastrointestinal bleeding and endotherapy with successful variceal eradication in the last 4 week.
Exclusion Criteria
1) Variceal Bleed,
2) Pregnancy.,
3) Patients on anticoagulation
4) Patients who refused to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Control of bleeding for next 24 hrs in both the groupTimepoint: 24 hours
- Secondary Outcome Measures
Name Time Method Incidence of TRALI (Transfusion associated lung injury) and TACO ( Transfusion associated circulatory overload) in both the groupsTimepoint: 24 hours;Early mortality ( 6 weeks) and late mortality ( 6 weeks) in both the groups.Timepoint: 6 weeks;TEG (Thromboelastography) abnormalities in patients with coagulopathy related bleeding,Timepoint: 24 hours;The clinical utility of TEG (Thromboelastography) over standard coagulation test.Timepoint: 24 hours